"cell lung" trang 6 - tải miễn phí từ tailieunhanh
Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
12    32    1
Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer

Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer
17    18    1
Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy
13    18    1
Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively

Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively
10    48    1
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: Treatment with tolvaptan

A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: Treatment with tolvaptan
6    33    1
LncRNA SNHG10 is downregulated in nonsmall cell lung cancer and predicts poor survival

LncRNA SNHG10 is downregulated in nonsmall cell lung cancer and predicts poor survival
6    56    1
Characteristics of non-small-cell lung cancer with interstitial pneumonia: Variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia

Characteristics of non-small-cell lung cancer with interstitial pneumonia: Variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia
10    38    1
Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: A retrospective study of the Merseyside and Cheshire Cancer network

Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: A retrospective study of the Merseyside and Cheshire Cancer network
8    41    1
LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25

LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25
7    33    1
LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1

LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1
6    22    1
PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression in pulmonary emphysema and chronic obstructive pulmonary disease with resected lung squamous cell carcinoma

PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression in pulmonary emphysema and chronic obstructive pulmonary disease with resected lung squamous cell carcinoma
7    40    1
Implantation of 125I radioactive seeds via c-TBNA combined with chemotherapy in an advanced non-small-cell lung carcinoma patient

Implantation of 125I radioactive seeds via c-TBNA combined with chemotherapy in an advanced non-small-cell lung carcinoma patient
5    42    1
Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: A retrospective study

Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: A retrospective study
9    32    1
Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment

Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment
6    31    1
Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
8    37    1
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using reallife data

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using reallife data
11    44    1
Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1- rearranged advanced non-small cell lung cancer (NSCLC) in Canada

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1- rearranged advanced non-small cell lung cancer (NSCLC) in Canada
13    53    1
A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: A large population-based study

A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: A large population-based study
8    40    1
Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer

Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer
9    56    1
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: A retrospective cohort study

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: A retrospective cohort study
14    53    1